Tradestie Institutional Equity Comparison Engine
IIF vs RDY โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
RDY Overall Edge
RDY Captures Institutional Edge (3โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Dr. Reddy's Laboratories Limited American Depositary Shares (RDY) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, IIF trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus RDY at 31.6x Forward P/E and 9.1% operating margin (-1.5% YoY). In options structure, IIF sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against RDY sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
RDY
IIF N/M vs RDY 31.6x Fwd P/E
Growth & Margin Winner
RDY
Op Margin N/A vs 9.1% ยท YoY N/A vs -1.5%
Momentum & Technical Winner
RDY
1Y -12.2% vs +6.0% ยท 52W Pos 47% vs 78%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
IIF
NYSE
Morgan Stanley India Investment Fund, Inc.
Institutional Equity
$23.43
-0.38% 1D
Market Cap
$253.3M
1M Return
+7.33%
1Y Return
-12.21%
Forward P/E
N/M
Unified AI Score
31.5 / 100
SELL
Tech 5.0
Fund 31.0
Flow 50.0
Mom 54.0
RDY
NYSE
Dr. Reddy's Laboratories Limited American Depositary Shares
Pharmaceutical Preparations
$14.70
-0.27% 1D
Market Cap
$12.3B
1M Return
+12.47%
1Y Return
+5.98%
Forward P/E
31.6x
Unified AI Score
34.7 / 100
SELL
Tech 17.0
Fund 34.0
Flow 50.0
Mom 40.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
IIF -12.21%
RDY +5.98%
Spread: +18.19 pp (RDY Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
IIF TTM Op. Margin: N/A
RDY TTM Op. Margin: 9.1%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IIF vs RDY. Trailing 12-month operating profitability (IIF N/A vs RDY 9.1%) and valuation multiples (IIF N/M vs RDY 31.6x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | IIF | RDY | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $253.3M | $12.3B | Larger Scale | RDY |
| Trailing P/E Ratio Valuation | N/M | 40.9x | Lower Multiple | RDY |
| Forward P/E Ratio Valuation | N/M | 31.6x | Lower Multiple | RDY |
| Revenue Growth (YoY) Growth | N/A | -1.5% | Higher Growth | RDY |
| Operating Margin (TTM) Profitability | N/A | 9.1% | Higher Margin | RDY |
| Net Profit Margin Profitability | N/A | 8.5% | Higher Margin | RDY |
| Return on Equity (ROE) Capital Efficiency | N/A | 7.3% | Higher ROE | RDY |
| 52-Week Range Position Momentum | 47% ($20โ$28) | 78% ($11โ$16) | Stronger Trend | RDY |
| Beta / 30D Volatility Risk Regime | 0.69ฮฒ ยท 21% Vol | 0.39ฮฒ ยท 24% Vol | Lower Realized Risk | IIF |
| Unified Institutional Score Composite Signal | 31.5 / 100 (SELL) | 34.7 / 100 (SELL) | Higher Composite | RDY |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full IIF vs RDY Buy Guide
IIF
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
RDY
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither IIF nor RDY registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.